Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Lozenge vs Tobacco-Free Snuff for Smokeless Tobacco Reduction
NCT01018394Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2009
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of nicotine in tobacco dependence (2 arms), sponsored by Mayo Clinic. Primary endpoint: Tobacco Abstinence at 12 Weeks. Started Jan 2009; status: completed.
02
Drugs
nicotine
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT01018394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01018394.